RDD Pharma, Innovate Biopharmaceuticals and Naia Rare Diseases merged and formed 9 Meters Biopharma, which will develop treatments for orphan diseases and unmet needs in gastroenterology.
GI & Endoscopy
Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of April 27-May 1:
A combination of liquid biopsy screening tests and conventional screening practices could present a more complete oncology picture, according to a study published in Science.
Here are six updates from gastroenterology companies and practices from the past week:
Gastroenterology-focused group purchasing organization Gastrologix partnered with Clinical Research Strategy Group to facilitate discounted rates to CSRG's clinical trial management platform.
Advertisement
The American Gastroenterological Association partnered with EndoscopyNow to provide AGA members access to a centralized platform with news, clinical data, procedural insights and product information.
Exact Sciences pre-announced some first quarter 2020 financial figures and will post $348 million in first quarter revenues.
The American Gastroenterological Association and the Digestive Health Physicians Association have drafted guidance for gastroenterologists to restart elective endoscopy procedures during the COVID-19 pandemic.
University Gastroenterology installed Jonathan Friedman as chief operating officer, the Providence Journal reports.
CRH Medical Corp. appointed Brian Griffin to its board of directors, the Vancouver, Canada-based company announced April 23.